CY1107583T1 - Γελη πepιλαμβανουσα τουλαχιστον ενα ρετινοειδες και βενζοϋλο-υπepοξειδιο - Google Patents

Γελη πepιλαμβανουσα τουλαχιστον ενα ρετινοειδες και βενζοϋλο-υπepοξειδιο

Info

Publication number
CY1107583T1
CY1107583T1 CY20071100120T CY071100120T CY1107583T1 CY 1107583 T1 CY1107583 T1 CY 1107583T1 CY 20071100120 T CY20071100120 T CY 20071100120T CY 071100120 T CY071100120 T CY 071100120T CY 1107583 T1 CY1107583 T1 CY 1107583T1
Authority
CY
Cyprus
Prior art keywords
toulahiston
pepilamvanused
hypotoxide
benzoil
retinoids
Prior art date
Application number
CY20071100120T
Other languages
English (en)
Inventor
Sandrine Orsoni
Nathalie Willcox
Original Assignee
Galderma Research & Development, S.N.C.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8870899&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY1107583(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Galderma Research & Development, S.N.C. filed Critical Galderma Research & Development, S.N.C.
Publication of CY1107583T1 publication Critical patent/CY1107583T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Toxicology (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Η ευρεσιτεχνία αναφέρεται σε σύνθεση περιλαμβάνουσα, εντός μέσου φυσιολογικώς παραδεκτού, ένα τουλάχιστον ρετινοειδές, βενζοϋλο-υπεροξείδιο σε διασπορά, και ένα τουλάχιστον παράγοντα σχηματισμού γέλης μη-εξαρτώμενον από το pΗ, σε μέθοδο παρασκευής της συνθέσεως αυτής, και στην χρήση της στην κοσμητική και στην δερματολογία.
CY20071100120T 2001-12-21 2007-01-29 Γελη πepιλαμβανουσα τουλαχιστον ενα ρετινοειδες και βενζοϋλο-υπepοξειδιο CY1107583T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0116747A FR2833841B1 (fr) 2001-12-21 2001-12-21 Gel comprenant au moins un retinoide et du peroxyde de benzoyle
EP02799797A EP1458369B1 (fr) 2001-12-21 2002-12-09 Gel comprenant au moins un retinoide et du peroxyde de benzoyle

Publications (1)

Publication Number Publication Date
CY1107583T1 true CY1107583T1 (el) 2013-03-13

Family

ID=8870899

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20071100120T CY1107583T1 (el) 2001-12-21 2007-01-29 Γελη πepιλαμβανουσα τουλαχιστον ενα ρετινοειδες και βενζοϋλο-υπepοξειδιο

Country Status (22)

Country Link
EP (1) EP1458369B1 (el)
JP (2) JP4889922B2 (el)
KR (1) KR101014586B1 (el)
CN (1) CN1329025C (el)
AR (1) AR038026A1 (el)
AT (1) ATE347354T1 (el)
AU (2) AU2002364437B2 (el)
BR (1) BRPI0214264B8 (el)
CA (1) CA2466321C (el)
CY (1) CY1107583T1 (el)
DE (2) DE60216634T2 (el)
DK (1) DK1458369T3 (el)
ES (1) ES2275948T3 (el)
FR (2) FR2833841B1 (el)
HU (1) HU230439B1 (el)
MX (1) MXPA04005918A (el)
PL (1) PL220838B1 (el)
PT (1) PT1458369E (el)
RU (1) RU2320327C2 (el)
SI (1) SI1458369T1 (el)
WO (1) WO2003055472A1 (el)
ZA (1) ZA200403759B (el)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7820186B2 (en) 2001-12-21 2010-10-26 Galderma Research & Development Gel composition for once-daily treatment of common acne comprising a combination of benzoyl peroxide and adapalene and/or adapalene salt
FR2833841B1 (fr) * 2001-12-21 2005-07-22 Galderma Res & Dev Gel comprenant au moins un retinoide et du peroxyde de benzoyle
EP1813312A3 (en) * 2002-09-05 2010-03-24 Galderma Research & Development Depigmenting composition for the skin comprising adapalene and at least one depigmenting agent
US7544674B2 (en) 2002-10-25 2009-06-09 Galderma S.A. Topical skin care composition
EP1809244B1 (en) * 2004-11-09 2010-05-12 Imaginative Research Associates, Inc. Retinoid solutions and formulations made therefrom
EP1919606A2 (en) 2005-08-02 2008-05-14 Sol-Gel Technologies Ltd. Metal oxide coating of water insoluble ingredients
FR2889662B1 (fr) * 2005-08-11 2011-01-14 Galderma Res & Dev Emulsion de type huile-dans-eau pour application topique en dermatologie
CA2616915A1 (en) * 2005-09-02 2007-05-10 Isabelle Pelisson Depigmenting composition for the skin, comprising adapalene, at least one depigmenting agent and at least one anti-inflammatory agent
FR2890314B1 (fr) * 2005-09-02 2009-03-20 Galderma Res & Dev Compositiondepigmentante de la peau comprenant de l'adapalene au moins un agent depigmentant et au moins un agent anti-inflammatoire
BRPI0709674A2 (pt) * 2006-03-31 2011-12-06 Stiefel Res Australia Pty Ltd gel de suspensão espumante
FR2901139B1 (fr) * 2006-05-17 2009-03-20 Galderma Res & Dev S N C Snc Compositions comprenant au moins un derive de l'acide naphtoique et du peroxyde de benzoyle, leurs procedes de preparation, et leurs utilisations
FR2903604B1 (fr) 2006-07-13 2008-09-05 Galderma Res & Dev S N C Snc Composition comprenant un retinoide et du peroxyde de benzoyle
FR2903603B1 (fr) 2006-07-13 2009-03-20 Galderma Res & Dev S N C Snc Combinaison d'adapalene et de peroxyde de benzole dans le traitement de l'acne
EP3184108A1 (en) * 2006-07-13 2017-06-28 Galderma Research & Development Composition comprising a retinoid and benzoyl peroxide
US8080537B2 (en) 2006-07-13 2011-12-20 Galderma Research & Development Combinations of adapalene and benzoyl peroxide for treating acne lesions
FR2909000B1 (fr) * 2006-11-28 2009-02-06 Galderma Res & Dev S N C Snc Compositions comprenant du peroxyde de benzoyle, au moins un derive de l'acide naphtoique et au moins un compose de type polymeres de polyurethane ou des derives de celui-ci, et leurs utilisations.
FR2910320B1 (fr) * 2006-12-21 2009-02-13 Galderma Res & Dev S N C Snc Emulsion comprenant au moins un retinoide et du peroxyde de benzole
FR2910321B1 (fr) * 2006-12-21 2009-07-10 Galderma Res & Dev S N C Snc Gel creme comprenant au moins un retinoide et du peroxyde de benzole
CA2677167A1 (en) 2007-01-30 2008-08-07 Galderma Research & Development Use of adapalene and benzoyl peroxide for the long term treatment of acne vulgaris
BRPI0808163A2 (pt) 2007-02-01 2014-11-04 Sol Gel Technologies Ltd Composição para aplicação tópica, métodos para tratar uma condição de superfície em um indivíduo, para preparar uma composição, e para usar o kit, e, kit
EP1967180A1 (de) * 2007-03-06 2008-09-10 Almirall Hermal GmbH Topische Zusammensetzung enthaltend einen Retinoid-Rezeptor-Agonist
FR2916975B1 (fr) * 2007-06-11 2009-09-04 Galderma Res & Dev Compositions comprenant au moins un compose retinoide, un compose anti-irritant et du peroxyde de benzoyle, et leurs utilisations
FR2916966B1 (fr) * 2007-06-11 2011-01-14 Galderma Res & Dev Compositions comprenant au moins un compose retinoide, un compose anti-irritant et du peroxyde de benzoyle, et leurs utilisations
EP2065032A1 (en) * 2007-11-27 2009-06-03 Galderma Research & Development A method for producing adapalene gels
CN105287484A (zh) * 2007-11-30 2016-02-03 盖尔德马研究及发展公司 含有萘甲酸衍生物、过氧化苯甲酰和成膜剂的组合物
CN102056481A (zh) * 2008-06-05 2011-05-11 陶氏制药科学公司 包含低浓度的在水和水混溶性有机溶剂中的悬浮液形式的过氧苯甲酰的局部药物制剂
EA029534B1 (ru) 2008-11-07 2018-04-30 Клокс Текнолоджиз Инк. Комбинация оксиданта и фотоактиватора для заживления ран
WO2011042902A2 (en) * 2009-10-07 2011-04-14 Tagra Biotechnologies Ltd Microcapsules comprising benzoyl peroxide and topical compositions comprising them
RU2572693C2 (ru) * 2009-10-21 2016-01-20 Дау Фармасьютикал Сайенсиз, Инк. Способ смачивания порошка, содержащего пероксид бензоила
WO2011098391A1 (en) 2010-02-09 2011-08-18 Galderma Research & Development A dermatological composition comprising a combination of adapalene and benzoyl peroxide for the treatment of acne in non- caucasian population with decrease of post- inflammatory hyperpigmentation
FR2969492B1 (fr) * 2010-12-23 2013-07-05 Galderma Res & Dev Mousses dermatologiques obtenues a partir d'un gel ou d'une suspension contenant de l'adapalene
FR2969491B1 (fr) * 2010-12-23 2013-07-12 Galderma Res & Dev Mousses dermatologiques obtenues a partir d'un gel ou d'une suspension contenant une combinaison d'adapalene et de bpo
US8563535B2 (en) 2011-03-29 2013-10-22 Kamal Mehta Combination composition comprising benzoyl peroxide and adapalene
CA2870690A1 (en) 2012-05-25 2013-11-28 Galderma Research & Development Treatment of preadolescent moderate acne vulgaris
CN104918598B (zh) * 2012-11-13 2018-12-04 盖尔德玛公司 Bpo清洗凝胶组合物
US9687465B2 (en) 2012-11-27 2017-06-27 Sol-Gel Technologies Ltd. Compositions for the treatment of rosacea
WO2015091828A1 (en) 2013-12-19 2015-06-25 Galderma Research & Development Therapy regimen for treating severe acne related diseases
US20170020833A1 (en) 2014-04-01 2017-01-26 Galderma Research & Development Method for treating and/or preventing acne scars with a fixed combination of adapalene or its salts and benzoyl peroxide
MX2017000717A (es) 2014-07-25 2017-05-01 Galderma Res & Dev Combinacion de adapaleno y peroxido de benzoilo para el tratamiento del acne grave.
EP3337472A4 (en) * 2015-08-20 2019-05-15 Sol-Gel Technologies Ltd. COMPOSITIONS FOR TOPICAL USE WITH BENZOYL PEROXIDE AND ADAPALS
WO2018080284A1 (ko) * 2016-10-31 2018-05-03 (주)동구바이오제약 여드름 치료용 약물의 생체이용률을 증진시키는 약학적 조성물
CN106729722B (zh) * 2016-11-21 2020-05-12 成都山信药业有限公司 一种制备稳定复方制剂的方法及复方制剂
EP3946597A1 (en) * 2019-04-04 2022-02-09 Galderma Holding SA Isopropylcarbonate benzoyl peroxide compositions and methods of use
WO2023112664A1 (ja) * 2021-12-14 2023-06-22 ロート製薬株式会社 過酸化ベンゾイルを含有する医薬外用組成物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2378523A1 (fr) * 1977-01-26 1978-08-25 Grupper Charles Medicament pour le traitement de l'acne
US4189501A (en) * 1977-10-07 1980-02-19 A. H. C. Pharmacal, Inc. Composition and method for the treatment of acne
LU85849A1 (fr) * 1985-04-11 1986-11-05 Cird Derives benzonaphtaleniques,leur procede de preparation et leur application dans les domaines pharmaceutiques et cosmetiques
US4792452A (en) * 1987-07-28 1988-12-20 E. R. Squibb & Sons, Inc. Controlled release formulation
FR2628319B1 (fr) * 1988-03-09 1990-12-07 Oreal Compositions pharmaceutiques et cosmetiques a base de peroxyde de benzoyle et de sels d'ammonium quaternaires
DK0608353T3 (da) * 1991-10-16 1996-07-01 Richardson Vicks Inc Vandig, kosmetisk gel med lav pH-værdi og indeholdende ikke-ioniske polyacrylamidderivater
US5470884A (en) * 1994-05-19 1995-11-28 Procter & Gamble Anti-acne compositions
FR2787322B1 (fr) * 1998-12-18 2002-10-18 Galderma Res & Dev Emulsion huile-dans-eau comprenant un agent actif micronise et un systeme emulsionnant approprie
JP2003525873A (ja) * 1999-12-20 2003-09-02 ヘンケル・コマンディットゲゼルシャフト・アウフ・アクチエン タブレット化増粘系
FR2833841B1 (fr) * 2001-12-21 2005-07-22 Galderma Res & Dev Gel comprenant au moins un retinoide et du peroxyde de benzoyle

Also Published As

Publication number Publication date
CA2466321A1 (fr) 2003-07-10
DK1458369T3 (da) 2007-04-10
RU2320327C2 (ru) 2008-03-27
DE60216634D1 (de) 2007-01-18
FR08C0024I1 (el) 2008-07-18
MXPA04005918A (es) 2004-11-01
DE122008000041I1 (de) 2008-11-20
CN1607946A (zh) 2005-04-20
HUP0500006A2 (en) 2006-08-28
KR101014586B1 (ko) 2011-02-16
SI1458369T1 (sl) 2007-04-30
RU2004122429A (ru) 2005-03-20
AU2008246274A1 (en) 2008-12-11
EP1458369A1 (fr) 2004-09-22
EP1458369B1 (fr) 2006-12-06
FR2833841A1 (fr) 2003-06-27
PL372270A1 (en) 2005-07-11
KR20050016290A (ko) 2005-02-21
AU2002364437A1 (en) 2003-07-15
PL220838B1 (pl) 2016-01-29
ATE347354T1 (de) 2006-12-15
HUP0500006A3 (en) 2009-09-28
ES2275948T3 (es) 2007-06-16
FR08C0024I2 (el) 2009-11-20
ZA200403759B (en) 2005-11-30
JP4889922B2 (ja) 2012-03-07
CA2466321C (fr) 2011-11-08
FR2833841B1 (fr) 2005-07-22
JP2011037904A (ja) 2011-02-24
JP5478468B2 (ja) 2014-04-23
BRPI0214264B1 (pt) 2017-04-18
JP2005513146A (ja) 2005-05-12
AU2008246274B2 (en) 2011-05-19
BR0214264A (pt) 2004-09-21
CN1329025C (zh) 2007-08-01
PT1458369E (pt) 2007-03-30
BRPI0214264B8 (pt) 2021-05-25
AR038026A1 (es) 2004-12-22
AU2002364437B2 (en) 2008-08-21
HU230439B1 (hu) 2016-06-28
DE60216634T2 (de) 2007-09-27
WO2003055472A1 (fr) 2003-07-10

Similar Documents

Publication Publication Date Title
CY1107583T1 (el) Γελη πepιλαμβανουσα τουλαχιστον ενα ρετινοειδες και βενζοϋλο-υπepοξειδιο
AR032394A1 (es) Una composicion oral.
MX2009006216A (es) Emulsion que comprende al menos un retinoide y peroxido de benzoilo.
CY1117294T1 (el) Διασφαλισμενη εναντια σε καταχρηση μορφη χορηγησης
ES2161674T3 (es) Composicion anhidra de decoloracion de fibras queratinicas que comprende la asociacion de polimeros anfifilos anionicos y/o no ionicos que comprenden al menos una cadena grasa y polimeros sustantivos cationicos o anfoteros.
AR031301A1 (es) Composicion para la decoloracion o la deformacion permanente de fibras queratinicas que comprende un poliuretano asociativo cationico
CO5700698A2 (es) Composiciones y metodos para el cuidado oral y personal
AR048894A1 (es) Bandas multicapa blanqueadoras de dientes
AR025247A1 (es) Composiciones de granulos de carotenos-xantofilos, estables
ES2243801T3 (es) Equivalente de piel/cabello con papilas reconstruidas.
NO993028D0 (no) Vannbaserte alkoholhydroksykarboksylperoksid-sammensetninger, fremstilling og anvendelse herav
CY1105247T1 (el) Υποκατεστημενα παραγωγα c- κυκλοεξυλομεθυλαμινης
AR053006A1 (es) Composicion de cuidado oral blanqueadora en dos fases
CY1109361T1 (el) Υποκατεστημενες 4-αμινοκυκλοεξανολες
NO20032788D0 (no) Modafinil-forbindelse og cyklodekstrinblandinger
AR031299A1 (es) Una composicion de tintura de oxidacion para fibras queratinicas que comprende un poliuretano asociativo cationico
AR031452A1 (es) Composicion para la tintura de oxidacion de las fibras queratinicas que comprende un polimero asociativo y un agente nacarante
PE20040875A1 (es) Composiciones para el cuidado bucal
AR004077A1 (es) Una composicion particularmente cosmetica, y mas particularmente para la deformacion permanente de las fibras queratinicas.
AR032422A1 (es) Uso de inhibidores de il-18 para el tratamiento y/o prevencion de la enfermedad cardiaca
MXPA05005170A (es) Gel despigmentante alcoholico acuoso que contiene un derivado fenolico y un retinoide.
BR0211784A (pt) Método para reduzir o crescimento capilar humano, uso de alfa-difluorometilornitina, e composição cosmética usada para a redução do crescimento capilar humano
AR023815A1 (es) Solucion oral de prucalopride
AR045392A1 (es) Composiciones para el tratamiento del cabello
HUP0302136A2 (hu) Endogén véralvadást aktíváló vegyületek és alkalmazásuk az endogén véralvadás feltárásában